Thursday, December 26, 2013

Infomercial for Bio-Solutions Corp. (BISU) Type2 Defense Scheduled to Roll Out in January

Bio-Solutions announced that its infomercial for Type2 Defense, a glucose-stabilizing supplement, is scheduled to roll out in January 2014.

A powder blend, Type2 Defense is a natural supplement that is touted to assist in stabilizing healthy glucose levels and to provide strong antioxidants. This all-natural pure powder mix contains green tea, cinnamon extract (cinnulinPF), and blueberry flavors as well as the company’s proprietary Type2 Defense blend. When mixed with water, Type2 Defense becomes a flavorful and effective tool.

The most common form of diabetes, type II diabetes affects millions of Americans. Type2 Defense has been developed as an aid to support healthy blood glucose levels in health-conscious individuals and those diagnosed with type II diabetes and pre-diabetes.

Type2 Defense was developed by Dr. Chandrasekhar Mallangi, a former Nestle USA nutritional innovator and the developer of various Nestle USA product lines. A nutritional supplement, Type2 Defense is delivered in 6.89 gram plastic packets that are packaged in a box of 30 servings.

Product statements made regarding Type2 Defense have not been evaluated by the U.S. Food and Drug Administration.

A clip of Bio-Solutions’ completed infomercial can be viewed at http://vimeo.com/81549711

For information about Bio-Solutions, visit www.biosolutionscorp.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: